Adolescents: Assessment and Management of Hypercholesterolemia

Today, there are so many medications for lowering cholesterol, making it difficult to know which drug to use in an individual patient.  Statins are still the gold standard of treatment, but other medications to add to statins include monoclonal antibodies to PCSK9, a small interfering RNA (siRNA) that targets PCSK9 and is long-acting, a cholesterol absorption inhibitor, a citrate lyase inhibitor and bile acid sequestrants.  This session will discuss the effectiveness, safety and mechanisms of action of medications approved for cholesterol reduction; cholesterol management in adults without heart disease (primary prevention) and cholesterol management in adolescents.

Chair

Savitha Subramanian, MD

University of Washington

Adolescents: Assessment and Management of Hypercholesterolemia

Jennifer Kelley, MD, MSCE

Vanderbilt University Medical Center

Overview of Non-Statin Cholesterol Therapies

David Saxon, MD, MSc

University of Colorado

Primary Prevention in Adults: Strategies for Selecting Medications and Setting Goals

Cindy Bredefeld, DO, FNLA, FACE

New York University Grossman Long Island School of Medicine